ES2200706B1 - DERIVATIVES OF 4-4'-BIPIRIDIL-2-2'-BISOXAZOLES AND 4-4'-BIPIRIDIL-2-2'-BISTIAZOLES AS ANTINEOPLASICAL AGENTS. - Google Patents
DERIVATIVES OF 4-4'-BIPIRIDIL-2-2'-BISOXAZOLES AND 4-4'-BIPIRIDIL-2-2'-BISTIAZOLES AS ANTINEOPLASICAL AGENTS.Info
- Publication number
- ES2200706B1 ES2200706B1 ES200201938A ES200201938A ES2200706B1 ES 2200706 B1 ES2200706 B1 ES 2200706B1 ES 200201938 A ES200201938 A ES 200201938A ES 200201938 A ES200201938 A ES 200201938A ES 2200706 B1 ES2200706 B1 ES 2200706B1
- Authority
- ES
- Spain
- Prior art keywords
- bipiridil
- bistiazoles
- bisoxazoles
- derivatives
- bipyridyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000001028 anti-proliverative effect Effects 0.000 abstract 1
- 229940034982 antineoplastic agent Drugs 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 230000003211 malignant effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Derivados de 4-4''-Bipiridil-2-2''-bisoxazoles y 4-4''-bipiridil-2- 2''-bistiazoles como agentes antineoplásicos. La presente invención presenta nuevos derivados de 4-4''-bipiridil-2-2''- bisoxazoles y 4-4''-bipiridil-2-2''-bistiazoles de fórmula general I con actividad antiproliferativa, y concretamente, de células malignas como HT-29. Por otro lado, se indica en la presente patente el mecanismo de su producción industrial y su uso para el desarrollo de compuestos a farmacéuticos para el tratamiento de tumores humanos.Derivatives of 4-4 '' - Bipyridyl-2-2 '' - bisoxazoles and 4-4 '' - bipyridyl-2- 2 '' - bistiazoles as antineoplastic agents. The present invention presents new derivatives of 4-4 '' - bipyridyl-2-2 '' - bisoxazoles and 4-4 '' - bipyridyl-2-2 '' - bistiazoles of general formula I with antiproliferative activity, and specifically, of malignant cells like HT-29. On the other hand, the mechanism of its industrial production and its use for the development of compounds to pharmacists for the treatment of human tumors is indicated in the present patent.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200201938A ES2200706B1 (en) | 2002-08-16 | 2002-08-16 | DERIVATIVES OF 4-4'-BIPIRIDIL-2-2'-BISOXAZOLES AND 4-4'-BIPIRIDIL-2-2'-BISTIAZOLES AS ANTINEOPLASICAL AGENTS. |
PCT/ES2003/000424 WO2004016622A1 (en) | 2002-08-16 | 2003-08-14 | Derivatives of 4-4'-bipyridyl-2-2'-bisoxazoles and 4-4'-bipyridyl-2-2'-bistiazoles as antineoplasic agents |
AU2003260515A AU2003260515A1 (en) | 2002-08-16 | 2003-08-14 | Derivatives of 4-4'-bipyridyl-2-2'-bisoxazoles and 4-4'-bipyridyl-2-2'-bistiazoles as antineoplasic agents |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200201938A ES2200706B1 (en) | 2002-08-16 | 2002-08-16 | DERIVATIVES OF 4-4'-BIPIRIDIL-2-2'-BISOXAZOLES AND 4-4'-BIPIRIDIL-2-2'-BISTIAZOLES AS ANTINEOPLASICAL AGENTS. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2200706A1 ES2200706A1 (en) | 2004-03-01 |
ES2200706B1 true ES2200706B1 (en) | 2005-06-01 |
Family
ID=31725576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES200201938A Expired - Fee Related ES2200706B1 (en) | 2002-08-16 | 2002-08-16 | DERIVATIVES OF 4-4'-BIPIRIDIL-2-2'-BISOXAZOLES AND 4-4'-BIPIRIDIL-2-2'-BISTIAZOLES AS ANTINEOPLASICAL AGENTS. |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003260515A1 (en) |
ES (1) | ES2200706B1 (en) |
WO (1) | WO2004016622A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2344780B1 (en) * | 2009-03-03 | 2011-07-22 | Universidad De Barcelona | USEFUL BISTIAZOLIC COMPOUNDS FOR THE TREATMENT OF CANCER. |
ES2543918T3 (en) | 2010-09-02 | 2015-08-25 | Universitat De Barcelona | Fluorinated thiazoles useful for cancer treatment |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3148194A (en) * | 1961-07-03 | 1964-09-08 | Arapahoe Chemicals Inc | Certain 1, 4-bis[2(4-substituted, 5-phenyloxazolyl)] benzenes |
FR2066252A5 (en) * | 1970-10-20 | 1971-08-06 | Sumitomo Chemical Co | Oxazolyl optical brighteners for textiles and plastics |
DD260698A1 (en) * | 1986-11-27 | 1988-10-05 | Tech Hochschule C Schorlemmer | METHOD FOR THE PRODUCTION OF BIS-OXAZOLIUM SALTS |
JP2000318313A (en) * | 1999-05-07 | 2000-11-21 | Mitsui Chemicals Inc | Optical recording medium |
-
2002
- 2002-08-16 ES ES200201938A patent/ES2200706B1/en not_active Expired - Fee Related
-
2003
- 2003-08-14 AU AU2003260515A patent/AU2003260515A1/en not_active Abandoned
- 2003-08-14 WO PCT/ES2003/000424 patent/WO2004016622A1/en not_active Application Discontinuation
Non-Patent Citations (1)
Title |
---|
RICE, C. et al.: New multidentate ligands for supramolecular coordination chemistry: double and triple helical complexes of ligands containing pyridil and thiazol donor units. J. Chem. Society, Dalton Transactions, 2001, Vol. 5, páginas 550-559. Página 551, conjunto L3. * |
Also Published As
Publication number | Publication date |
---|---|
AU2003260515A1 (en) | 2004-03-03 |
AU2003260515A8 (en) | 2004-03-03 |
ES2200706A1 (en) | 2004-03-01 |
WO2004016622A1 (en) | 2004-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP045081A (en) | DERIVATIVES OF 1,8-NAFTIRIDINE AND ITS USE FOR THE TREATMENT OF DIABETES AND RELATED DISORDERS | |
HN2003000196A (en) | INDOLINFENYL SULFONAMIDE DERIVATIVES | |
IS2517B (en) | Use of substituted 2-aminotetralins in the prevention of Parkinson's disease | |
NO20040096L (en) | Taxol-improvement relations | |
CY1110889T1 (en) | C-ARYLIC GLUCOSYSTEMS SGLT2 INSPECTIONS AND METHOD FOR PRODUCTION | |
PL1809288T3 (en) | Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases | |
CU23105A3 (en) | NOVEDOUS DERIVATIVES OF AMINODICARBOXILIC ACID WITH PHARMACEUTICAL PROPERTIES | |
BRPI0408347A (en) | pyrimidine derivatives | |
PA8534801A1 (en) | PIPERAZINE DERIVATIVES | |
CY1107815T1 (en) | 1,3,3-DIFFERENTIALS AND 1,3,3-TRIPLIATED PYROLIDINES AS CONTAINERS OF HISTAMIN-3, AND THERAPEUTIC MEDICINES | |
BRPI0410633A (en) | pyridopyrazines and their use as kinase modulators | |
TW200637544A (en) | Medicaments for the treatment or prevention of fibrotic diseases | |
CY1110130T1 (en) | MORPHOLINE PRODUCTS FOR USE AS DOPAMINE AGONISTS IN THERAPEUTIC DISEASE Therapeutic Treatment I.A. | |
CR10092A (en) | NEW SUBSTITUTED ACICLIC FUROPIRIMIDINE DERIVATIVES AND THEIR USE | |
UY27018A1 (en) | PIRIMIDINE DERIVATIVES | |
CO6150166A2 (en) | NEW DERIVATIVES OF [1,3] TIAZOLO [4,5-D] PIRIMIDIN-2- (3H) -AMINA 5,7-DISUSTITUTED AND ITS USE IN THERAPY | |
DOP2006000257A (en) | DERIVATIVES OF 9-CHLORINE-15-DEOXIPROSTAGLANDIN, PROCESSES FOR ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT | |
ES2200706B1 (en) | DERIVATIVES OF 4-4'-BIPIRIDIL-2-2'-BISOXAZOLES AND 4-4'-BIPIRIDIL-2-2'-BISTIAZOLES AS ANTINEOPLASICAL AGENTS. | |
ECSP044971A (en) | ISOXAZOLOPIRIDINONAS AND ITS USE IN PARKINSON'S DISEASE TREATMENT | |
UY27451A1 (en) | 2,5-DIAMIDOINDOLES REPLACED AND ITS USE | |
DE60330391D1 (en) | CYCLOALKENIC DICARBOXYLIC COMPOUNDS AS ANTI-INFLAMMATORY, IMMUNOMATULATORY AND ANTIPROLIFERATIVE AGENTS | |
ES2183734B1 (en) | DERIVATIVES OF 4-4'-BIPIRIDIL-2-2'-BISOXAZOLES AND 4-4'-BIPIRIDIL-2-2'-BISTIAZOLES AS ANTINEOPLASICAL AGENTS. | |
TR200000637T2 (en) | Benzoxazin and benzothiazine derivatives and their use in drugs. | |
TR200600987T1 (en) | 7-carboxymethyloxy-3 ', 4', 5-trimethoxy flavone-monohydrate, preparation method and its use | |
AR023668A1 (en) | NEW BENZOILGUANIDINE DERIVATIVES WITH ADVANTAGE PROPERTIES, PROCEDURE FOR THEIR PREPARATION AND ITS USE IN THE PREPARATION OF MEDICINES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 20040301 Kind code of ref document: A1 |
|
FG2A | Definitive protection |
Ref document number: 2200706B1 Country of ref document: ES |
|
FD2A | Announcement of lapse in spain |
Effective date: 20211118 |